Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Uter Wolfgang, Aberer Werner, Armario-Hita José Carlos, Fernandez-Vozmediano José M, Ayala Fabio, Balato Anna, Bauer Andrea, Ballmer-Weber Barbara, Beliauskiene Aiste, Fortina Anna Belloni, Bircher Andreas, Brasch Jochen, Chowdhury Mahbub M U, Coenraads Pieter-Jan, Schuttelaar Marie-Louise, Cooper Sue, Czarnecka-Operacz Magda, Zmudzinska Maria, Elsner Peter, English John S C, Frosch Peter J, Fuchs Thomas, García-Gavín Juan, Fernández-Redondo Virginia, Gawkrodger David J, Giménez-Arnau Ana, Green Cathy M, Horne Helen L, Johansen Jeanne Duus, Jolanki Riitta, Pesonen Maria, King Clodagh M, Krêcisz Beata, Chomiczewska Dorota, Kiec-Swierczynska Marta, Larese Francesca, Mahler Vera, Ormerod Anthony D, Peserico Andrea, Rantanen Tapio, Rustemeyer Thomas, Sánchez-Pérez Javier, Sansom Jane E, Silvestre Juan Fco, Simon Dagmar, Spiewak Radoslaw, Statham Barry N, Stone Natalie, Wilkinson Mark, Schnuch Axel
Аннотация
METHODS: Data from the 39 departments in 11 European countries comprising the European Surveillance System on Contact Allergy network (www.essca-dc.org) in this period have been pooled and analysed according to common standards.
RESULTS: Patch test results with the European baseline series, and country-specific or department-specific additions to it, obtained in 25 181 patients, showed marked international variation. Metals and fragrances are still the most frequent allergens across Europe. Some allergens tested nationally may be useful future additions to the European baseline series, for example methylisothiazolinone, whereas a few long-term components of the European baseline series, namely primin and clioquinol, no longer warrant routine testing.
CONCLUSIONS: The present analysis points to 'excess' prevalences of specific contact sensitization in some countries, although interpretation must be cautious if only few, and possibly specialized, centres are representing one country. A comparison as presented may help to target in-depth research into possible causes of 'excess' exposure, and/or consideration of methodological issues, including modifications to the baseline series.